Vaxart Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Steven Lo
Chief Executive Officer (CEO)
n/a
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | less than a year |
Participación del CEO | n/a |
Permanencia media de la dirección | 2.5yrs |
Promedio de permanencia en la Junta Directiva | 2.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Here's Why Vaxart (NASDAQ:VXRT) Must Use Its Cash Wisely
Nov 08Vaxart (NASDAQ:VXRT) Will Have To Spend Its Cash Wisely
Jun 30Vaxart: The Market Still Isn't Buying Oral Vaccine Thesis
Sep 09Ray Stapleton joins Vaxart as CTO
Aug 31Vaxart shareholders approve proposal to increase number of shares
Aug 05Vaxart continues to lobby shareholders to vote to increase number of shares
Jul 29Vaxart oral COVID-19 pill vaccine candidate induces long-lasting antibodies against SARS-CoV-2
Jul 20Vaxart says recent CRO agreement 'may be integral' to oral COVID vaccine success
Jul 07Vaxart: A Unique Vaccine Concern
Jun 14Vaxart: A Speculative Biotech With Potential As Covid-19 Play And Oral Vaccine Platform
Feb 26Vaxart: Investment Case For An Oral COVID Vaccine Not So Hard To Swallow
Dec 09Vaxart: Differentiated Covid Oral Route Remains Viable
Nov 16Vaxart: A Close Look At Their COVID-19 Oral Tablet Vaccine Program
Oct 30Vaxart: An Update
Oct 02Companies Like Vaxart (NASDAQ:VXRT) Are In A Position To Invest In Growth
Aug 25Vaxart: World's First Oral COVID Vaccine In Development
Jul 25FDA is set to decline new emergency use authorizations for COVID-19 vaccines
May 26We're Hopeful That Vaxart (NASDAQ:VXRT) Will Use Its Cash Wisely
May 11Enrollment underway in Vaxart's early-stage norovirus trial in elderly population
May 07Vaxart EPS misses by $0.04, misses on revenue
May 03Plucky Underdog Vaxart Still Banging Drum For Oral Vaccination
Apr 30Vaxart is soaring on more than 10 times the two-month average volume
Apr 27Shareholders Are Thrilled That The Vaxart (NASDAQ:VXRT) Share Price Increased 231%
Mar 03CEO
Steven Lo (56 yo)
less than a year
Permanencia
Mr. Steven Lo serves as President, CEO & Director of Vaxart, Inc. since March 18, 2024. He has been Director at Zosano Pharma Corporation since October 2019 and serves as its President and Chief Executive...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Senior VP & Chief Scientific Officer | 14.3yrs | US$1.14m | 0.24% $ 307.3k | |
Chief Medical Officer | 2.8yrs | US$1.17m | 0.083% $ 108.9k | |
President | less than a year | sin datos | sin datos | |
CFO, Principal Financial Officer & Principal Accounting Officer | 1.4yrs | sin datos | 0.044% $ 57.4k | |
Chief Technology Officer | 1.8yrs | sin datos | sin datos | |
Senior VP & General Counsel | 2.3yrs | sin datos | 0.064% $ 83.6k | |
Senior Vice President of Clinical Development & Project Management | 4.2yrs | sin datos | sin datos | |
Senior Vice President of Quality | 3.3yrs | sin datos | sin datos |
2.5yrs
Permanencia media
55.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de VXRT se considera experimentado (2.4 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | less than a year | sin datos | sin datos | |
Independent Director | 4.6yrs | US$92.26k | 0.0063% $ 8.2k | |
Member of Scientific & Clinical Advisory Board | 2.8yrs | sin datos | sin datos | |
Independent Director | 1.8yrs | US$89.08k | 0.010% $ 13.0k | |
Independent Chairman of the Board | 6.3yrs | US$109.57k | 0.38% $ 489.9k | |
Member of Scientific & Clinical Advisory Board | 2.8yrs | sin datos | sin datos | |
Independent Director | 3.1yrs | US$93.72k | 0.0042% $ 5.4k | |
Member of Scientific & Clinical Advisory Board | 2.8yrs | sin datos | sin datos | |
Independent Director | 1.8yrs | US$94.76k | 0.020% $ 25.7k | |
Member of Scientific & Clinical Advisory Board | 2.8yrs | sin datos | sin datos | |
Member of Scientific & Clinical Advisory Board | 2.8yrs | sin datos | sin datos | |
Member of Scientific & Clinical Advisory Board | 2.8yrs | sin datos | sin datos |
2.8yrs
Permanencia media
65yo
Promedio de edad
Junta con experiencia: La junta directiva de VXRT no se considera experimentada (2.7 años de permanencia promedio), lo que sugiere una nueva junta directiva.